Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(H05BA01) |
Calcitonin (salmon synthetic) |
2451 |
|
OUTPAT |
OUTPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
2199 |
|
OUTPAT |
OUTPAT_ICD10(E210) |
Primary hyperparathyroidism |
1630 |
|
INPAT |
INPAT_ICD10(E2109) |
Other primary hyperparathyroidism |
1317 |
|
OUTPAT |
OUTPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
898 |
|
INPAT |
INPAT_ICD10(E210) |
Primary hyperparathyroidism |
628 |
|
PURCH |
PURCH_ATC(H05BX01) |
Cinacalcet |
591 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E2109) |
Other primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
577 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E213) |
Hyperparathyroidism, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
491 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E210) |
Primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
469 |
|
INPAT |
INPAT_ICD10(E213) |
Hyperparathyroidism, unspecified |
423 |
|
OUTPAT |
OUTPAT_ICD10(E212) |
Other hyperparathyroidism |
362 |
|
OUTPAT |
OUTPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
196 |
|
INPAT |
INPAT_ICD10(E212) |
Other hyperparathyroidism |
158 |
|
PURCH |
PURCH_ATC(H05BX02) |
Paricalcitol |
127 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E212) |
Other hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
112 |
|
INPAT |
INPAT_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified |
95 |
|
INPAT |
INPAT_ICD9(2520A) |
Hyperparathyroidism |
89 |
|
INPAT |
INPAT_ICD8(25200) |
Diseases of parathyroid gland, Hyperparathyroidism |
73 |
|
PRIM_OUT |
PRIM_OUT_NOT_USED_ICD10(E211) |
Secondary hyperparathyroidism, not elsewhere classified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! |
33 |
|
DEATH |
DEATH_ICD10(E210) |
Primary hyperparathyroidism |
7 |
|